Prognostic significance of NANOG and KLF4 for breast cancer

Breast Cancer

Volumn 21, Issue 1, 2014, Pages 96-101

  Nagata, Takuya ^a   Shimada, Yutaka ^a   Sekine, Shinichi ^a   Hori, Ryota ^a   Matsui, Koshi ^a   Okumura, Tomoyuki ^a   Sawada, Shigeaki ^a   Fukuoka, Junya ^a   Tsukada, Kazuhiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Breast cancer; iPS cells; KLF4; NANOG

Indexed keywords

ANTINEOPLASTIC AGENT; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEGMENTAL MASTECTOMY; SURVIVAL RATE; WIDE EXCISION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MIDDLE AGED; OCTAMER TRANSCRIPTION FACTOR-3; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84891556597     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-012-0357-y     Document Type: Article

References (18)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-76.
2. Yu J, Vodyanik MA, Smuga OK, Antosiewicz BJ, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-20.
3. Monsef N, Soller M, Isaksson M, Abrahamsson PA, Panagopoulos I. The expression of pluripotency marker Oct3/4 in prostate cancer and benign prostate hyperplasia. Prostate. 2009;69:909-16.
4. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol. 2008;9:625-35.
5. Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem. 2008;280:24731-7.
6. Soucek L, Evan GI. The ups and downs of Myc biology. Curr Opin Genet. 2010;20:91-5.
7. Evans PM, Liu C. Roles of Krupel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin. 2008;7:554-64.
8. Ezeh UI, Turek PJ, Reijo RA, Clark AT. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer. 2005;104:2255-65.
9. Deming SL, Nass SJ, Dickson RB, Trock BJ. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer. 2000;83:1688-95.
10. Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, et al. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res. 2004;10:4314-24.
11. Yamanaka S. Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci. 2008;363:2079-87.
12. Jeter CR, Liu B, Liu X, Chen X, Liu C, et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 2011;30:3833-45.
13. Leis O, Eguiara A, Arribillaga EL, Alberdi MJ, Garcia SH, et al. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene. 2012;31:1354-65.
14. Naderi A, Weschendorff AE, Barbosa-Morais NL. A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene. 2007;26:1507-16.
15. Akaogi K, Nakajima Y, Ito I, Kawasaki S, Oie SH, Murayama A, et al. KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha. Oncogene. 2009;28:2894-902.
16. Al-Haji M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983-8.
17. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005;65:5506-11.
18. Cai GL, Ying L, Bin BW, Yan JZ, Rui SZ, et al. Clinical implications of stem cell gene Oct-4 expression in breast cancer. Ann Surg. 2011;253:1165-71.